“Incidence of Adverse Events in Patients With Metastatic Breast Cancer During Use of Standard and on Off Capecitabine Protocols”. Research, Society and Development, vol. 11, no. 8, June 2022, p. e3711830426, https://doi.org/10.33448/rsd-v11i8.30426.